More Info

General Info
Backed by NexMed, USA and Bio-Quant, Inc., its revenue generating CRO business, Apricus Biosciences has leveraged the flexibility of its proven NexACT drug delivery technology to enable multi-route administration of new and improved compounds across numerous therapeutic classes. Future growth is expected to be driven primarily through out-licensing of this technology for the development and commercialization of such compounds to pharmaceutical and biotechnology companies, worldwide. Concurrently, the company is seeking to monetize its existing product pipeline, including its approved drug erectile dysfunction treatment, Vitaros, as well as compounds in development from pre-clinical through Phase 3, currently focused on dermatology, sexual dysfunction and cancer.
Extra Phones

Fax: (858) 866-0482

Category

Reviews

Hi there!
Be the first to review!
What do you rate this business?First-classBetter than mostAbout what I expectedNot the worst...Disappointing
Click to Rate

Details

Phone: (646) 293-2100

Address: 300 Park Ave, New York, NY 10022

Website: https://seelostherapeutics.com

People Also Viewed